T. Giannakakis

544 total citations
24 papers, 457 citations indexed

About

T. Giannakakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, T. Giannakakis has authored 24 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in T. Giannakakis's work include Cancer Treatment and Pharmacology (13 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (5 papers). T. Giannakakis is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (5 papers). T. Giannakakis collaborates with scholars based in Greece, United States and South Korea. T. Giannakakis's co-authors include George Fountzilas, Dimosthenis Skarlos, Sofia Agelaki, Dimitrios Bafaloukos, P. Kosmidis, George Samonis, A. Athanassiades, Dimitriοs Mavroudis, Nikolaos Malamos and Anna Potamianou and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

T. Giannakakis

24 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Giannakakis Greece	13	367	121	90	79	68	24	457
Mario Rabinovich Argentina	11	339 0.9×	114 0.9×	109 1.2×	42 0.5×	85 1.3×	17	467
M Namer France	12	271 0.7×	84 0.7×	116 1.3×	94 1.2×	55 0.8×	36	442
Alberto Romero Argentina	10	228 0.6×	88 0.7×	92 1.0×	39 0.5×	71 1.0×	19	352
H. Franklin Netherlands	9	416 1.1×	55 0.5×	215 2.4×	115 1.5×	96 1.4×	11	535
Concepción Fernández‐Chacón Spain	5	252 0.7×	108 0.9×	75 0.8×	76 1.0×	61 0.9×	6	374
Smitha Menon United States	11	300 0.8×	73 0.6×	128 1.4×	134 1.7×	29 0.4×	18	474
Ewa Chmielowska Poland	12	251 0.7×	59 0.5×	132 1.5×	109 1.4×	47 0.7×	44	468
Anna Maria Mosconi Italy	13	364 1.0×	134 1.1×	90 1.0×	140 1.8×	69 1.0×	39	558
J.T. Soper United States	9	165 0.4×	54 0.4×	112 1.2×	72 0.9×	98 1.4×	14	417
S. Amato Argentina	8	171 0.5×	118 1.0×	53 0.6×	17 0.2×	63 0.9×	12	330

Countries citing papers authored by T. Giannakakis

Since Specialization

Citations

This map shows the geographic impact of T. Giannakakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Giannakakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Giannakakis more than expected).

Fields of papers citing papers by T. Giannakakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Giannakakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Giannakakis. The network helps show where T. Giannakakis may publish in the future.

Co-authorship network of co-authors of T. Giannakakis

This figure shows the co-authorship network connecting the top 25 collaborators of T. Giannakakis. A scholar is included among the top collaborators of T. Giannakakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Giannakakis. T. Giannakakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alexandraki, Krystallenia, John Grınıatsos, Nikiforos Ballian, et al.. (2010). Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. Journal of Endocrinological Investigation. 34(4). 255–259. 28 indexed citations

Stathopoulos, George P., J. Stathopoulos, D. Skarlos, et al.. (2005). Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study. Cancer Chemotherapy and Pharmacology. 57(6). 796–800. 12 indexed citations

Souglakos, John, A. Polyzos, A. Athanasiadis, et al.. (2004). Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3532–3532. 2 indexed citations

Stathopoulos, G., S. Rigatos, Meletios Α. Dimopoulos, et al.. (2003). Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. Annals of Oncology. 14(3). 388–394. 39 indexed citations

Tsavaris, Νicolas, Christos Kosmas, T. Giannakakis, et al.. (2003). Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study. Cancer Chemotherapy and Pharmacology. 52(6). 514–519. 26 indexed citations

Kosmas, Christos, Sofia Agelaki, T. Giannakakis, et al.. (2002). Phase I Study of Vinorelbine and Carboplatin Combination in Patients with Taxane and Anthracycline Pretreated Advanced Breast Cancer. Oncology. 62(2). 103–109. 3 indexed citations

Georgoulias, Vassilis, George Samonis, E. Papadakis, et al.. (2001). Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial. Lung Cancer. 34. 47–51. 29 indexed citations

Giannakakis, T., Stylianos Kakolyris, Dimitriοs Mavroudis, et al.. (2000). Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma. European Journal of Cancer. 36(6). 742–747. 11 indexed citations

Mavroudis, D., E. Papadakis, M. Veslemes, et al.. (2000). A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC). Lung Cancer. 29(1). 29–29. 11 indexed citations

10.

Kouroussis, Ch., Anna Potamianou, T. Giannakakis, et al.. (1999). Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study. Annals of Oncology. 10(5). 547–552. 33 indexed citations

11.

Mavroudis, Dimitriοs, Nikolaos Malamos, A. Alexopoulos, et al.. (1999). Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial. Annals of Oncology. 10(2). 211–216. 86 indexed citations

12.

Nicolaides, C., George Fountzilas, Nicholas Zoumbos, et al.. (1998). Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index. Oncology. 55(5). 405–415. 31 indexed citations

13.

Nicolaides, C., et al.. (1998). Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.. PubMed. 17(1). 71–5. 1 indexed citations

14.

Aravantinos, Gerasimos, D. Skarlos, P. Kosmidis, et al.. (1997). A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study. European Journal of Cancer. 33(1). 160–163. 10 indexed citations

15.

Fountzilas, George, A. Athanassiades, T. Giannakakis, et al.. (1997). A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study. Annals of Oncology. 8(12). 1213–1220. 28 indexed citations

16.

Skarlos, Dimosthenis, Gerasimos Aravantinos, C. Christodoulou, et al.. (1997). Chemotherapy with Methotrexate, Vinblastine, Epirubicin and Carboplatin (Carbo-MVE) in Transitional Cell Urothelial Cancer. European Urology. 31(4). 420–427. 15 indexed citations

17.

Bafaloukos, Dimitrios, N. Pavlidis, D. Skarlos, et al.. (1996). Recombinant Interferon ALFA-2A in Combination With Carboplatin, Vinblastine, and Bleomycin in the Treatment of Advanced Malignant Melanoma. American Journal of Clinical Oncology. 19(3). 296–300. 9 indexed citations

18.

Fountzilas, George, A. Athanassiades, T. Giannakakis, et al.. (1996). A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines. European Journal of Cancer. 32(1). 47–51. 49 indexed citations

19.

Pavlidis, Nicholas, et al.. (1996). Phase II Study of 5-Fluorouracil and Interferon-Gamma in Patients with Metastatic Colorectal Cancer. Oncology. 53(2). 159–162. 5 indexed citations

20.

Fountzilas, George, Dimosthenis Skarlos, T. Giannakakis, et al.. (1994). Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer. European Journal of Cancer. 30(7). 965–969. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact